Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment

Toxicological Sciences

Volumn 56, Issue 1, 2000, Pages 189-202

  Van Sittert, Niek J ^a   Megens, Hendricus J J J ^a   Watson, William P ^a   Boogaard, Peter J ^a  

^a Shell Intl Chemicals Research   (Netherlands)

Author keywords

1,3 butadiene; Biological monitoring; Biomarker; Carcinogenesis; DNA adducts; Hb adducts; Risk assessment; Urinary metabolites

Indexed keywords

1,2 DIHYDROXYBUTYLMERCAPTURIC ACID; 1,2 EPOXY 3 BUTENE; 1,3 BUTADIENE; ACETYLCYSTEINE DERIVATIVE; CELL DNA; HEMOGLOBIN DERIVATIVE; MONOHYDROXY 3 BUTENYLMERCAPTURIC ACID; UNCLASSIFIED DRUG;

AIR QUALITY; AIR SAMPLING; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CANCER RISK; COMPLEX FORMATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ERYTHROCYTE; GENOTOXICITY; HUMAN; MALE; MOUSE; NONHUMAN; OCCUPATIONAL CANCER; OCCUPATIONAL CARCINOGENESIS; OCCUPATIONAL EXPOSURE; RAT; RISK ASSESSMENT; SPECIES DIFFERENCE; TOXICOKINETICS; URINE LEVEL;

ANIMALIA;

EID: 0033938539     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/56.1.189     Document Type: Article

References (41)

1. Bechtold, W. E., Strunk, M. R., Chang, I. Y., Ward, J. B., Jr., and Henderson, R. F. (1994). Species differences in urinary butadiene metabolites: Comparisons of metabolite ratios between mice, rats, and humans. Toxicol. Appl. Pharmacol. 127, 44-49.
2. Boogaard, P. J., and Bond, J. A. (1996). The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol. 141, 617-627.
3. Boogaard, P. J., De Kloe, K. P., Richardson, K. A., Peters, M. M. C. G., Watson, W. P., and Van Sittert, N. J. (1998). DNA adduct profiles differ after 1,3-butadiene or 1,2-epoxy-3-butene and between rats and mice. Toxicol. Sci. 42, 83.
4. Boogaard, P. J., De Kloe, K. P., and Van Sittert, N. J. (2000). N7-(1-(Hydroxymethyl)-2,3-dihydroxypropyl)guanine is the major DNA adduct after exposure to 1,3-butadiene but not 1,2-epoxy-3-butene. Toxicol. Sci. 54, S229.
5. Boogaard, P. J., Sumner, S. C., and Bond, J. A. (1996). Glutathione conjugation of 1,2:3,4-diepoxybutane in human liver and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol. 136, 307-316.
6. Boogaard, P. J., and Van Sittert, N. J. (1995). Biological monitoring of exposure to benzene: A comparison between S-phenylmercapturic acid, trans,trans-muconic acid, and phenol. Occup. Environ. Med. 52, 611-620.
7. Boogaard, P. J., and Van Sittert, N. J. (1996). Suitability of S-phenylmercapturic acid and trans,trans-muconic acid as biomarkers for exposure to low concentrations of benzene. Environ. Health. Perspect. 104(Suppl. 6), 1151-1157.
8. Cochrane, J. E., and Skopek, T. R. (1994). Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15, 713-717.
9. Csanády, G. A., Guengerich, F. P., and Bond, J. A. (1992). Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13, 1143-1153.
10. Delzell, E., Sathiakumar, N., Hovinga, M., Macaluso, M., Julian, J., Larson, R., Cole, P., and Muir, D. C. (1996). A follow-up study of synthetic rubber workers. Toxicology 113, 182-189.
11. Divine, B. J., and Hartman, C. M. (1996). Mortality update of butadiene production workers. Toxicology 113, 169-181.
12. ECETOC, European Chemical Industry Ecology and Toxicology Centre (1997). 1,3-Butadiene OEL. Criteria document, 2nd ed. CAS No. 106-99-0. Special Report No. 12.
13. Ehrenberg, L., and Törnqvist, M. (1995). The research background for risk assessment of ethylene oxide: Aspects of dose. Mutat Res. 330, 41-54.
14. Elfarra, A. A., Sharer, J. E., and Duescher, R. J. (1995). Synthesis and characterization of N-acetyl-L-cysteine S-conjugates of butadiene monoepoxide and their detection and quantitation in urine of rats and mice given butadiene monoepoxide. Chem. Res. Toxicol. 8, 68-76.
15. Handley, K. E. (1994). Routes to labelled 1,3-butadiene and butadiene epoxides. Ph.D. Thesis. University of Newcastle upon Tyne, UK.
16. Himmelstein, M. W., Acquavella, J. F., Recio, L., Medinsky, M. A., and Bond, J. A. (1997). Toxicology and epidemiology of 1,3-butadiene by inhalation. Crit. Rev. Toxicol. 27, 1-108.
17. Hoet, P. (1996). General principles. In Biological Monitoring of Chemical Exposure in the Workplace, pp. 1-19. World Health Organization, Geneva.
18. IARC (1992). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 54, 237-285. IARC, Lyon.
19. Jones, A. R. (1975). The metabolism of 3-chloro-, 3-bromo- and 3-iodopropan-1,2-diol in rats and mice. Xenobiotica 5, 155-165.
20. Kemper, R. A., Elfarra, A. A., and Myers, S. R. (1998). Metabolism of 3-butene-1,2-diol in B6C3F1 mice. Evidence for involvement of alcohol dehydrogenase and cytochrome P450. Drug Metab. Dispos. 26, 914-920.
21. Lynch, J., Albertini, R. J., Šrám, S. R. Vacek, P., and Wright, M. (1999). External exposure assessment in a transitional epidemiological study. In Abstracts, Air Pollution: Understanding Air Toxics and Particles. The Fifteenth Health Effects Institute Annual Conference, San Diego, CA, p. 46.
22. Melnick, R. L., Huff, J., Chou, B. J., and Miller, R. A. (1990). Carcinogenicity of 1,3-butadiene in C57B1/6 × C3HF1 mice at low exposure concentrations. Cancer Res. 50, 6592-6599.
23. Moll, T. S., and Elfarra, A. A. (1999). Characterization of the reactivity, regioselectivity, and stereoselectivity of the reactions of butadiene monoepoxide with valinamide and the N-terminal valine of mouse and rat hemoglobin. Chem. Res. Toxicol. 12, 679-689.
24. Murg, M. N., Schuler, M., and Eastmond, D. A. (1999). Evaluation of micronuclei and chromosomal breakage in the 1cen-q12 region by the butadiene metabolites epoxybutene and diepoxybutane in cultured human lymphocytes. Mutagenesis 14, 541-546.
25. Osterman-Golkar, S., and Bond, J. A. (1996). Biomonitoring of 1,3-butadiene and related compounds. Environ. Health Perspect. 104(Suppl. 5), 907-915.
26. Osterman-Golkar, S. M., Bond, J. A., Ward, J. B., Jr., and Legator, M. S. (1993). Use of hemoglobin adducts for biomonitoring exposure to 1,3-butadiene. IARC Sci. Publ. 127, 127-134.
27. Osterman-Golkar, S., Kautiainen, A., Bergmark, E., Håkansson, K., and MäkiPaakkanen, J. (1991). Hemoglobin adducts and urinary mercapturic acids in rats as biological indicators of butadiene exposure. Chem. Biol. Interact. 80, 291-302.
28. Osterman-Golkar, S., Peltonen, K., Anttinen-Klemetti, T., Hindsø-Landin, H., Zorcec, V., and Sorsa, M. (1996). Haemoglobin adducts as biomarkers of occupational exposure to 1,3-butadiene. Mutagenesis 11, 145-149.
29. Owen, P. E., Glaister, J. R., Gaunt, I. F., and Pullinger, D. H. (1987). Inhalation toxicity studies with 1,3-butadiene: III. Two-year toxicity/carcinogenicity studies in rats. Am. Ind. Hyg. Assoc. J. 48, 407-413.
30. Pérez, H. L., Lähdetie, J., Landin, H., Kilpeläinen, I., Koivisto, P., Peltonen, K., and Osterman-Golkar, S. (1997). Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides. Chem. Biol. Interact. 105, 181-198
31. Richardson, K. A., Megens, H. J. J. J., Genuit, W. J., Van Velzen, G. J., Peters, M. M. C. G., Van Elburg, P., Boogaard, P. J., Watson, W. P., and Van Sittert, N. J (1998a). The fate of butadiene in experimental animals. IV. Measurement of total and specific haemoglobin adducts. CA.98.20328. Shell Research and Technology Centre, Amsterdam.
32. Richardson, K. A., Megens, H. J. J. J., Van Gaalen, F. C., Peters, M. M. C. G., Van Elburg, P. A., Watson, W. P., Boogaard, P. J., and Van Sittert, N. J. (1998b). Hb adduct profiles differ after 1,3-butadiene or 1,2-epoxy-3-butene and between rats and mice. Toxicol. Sci. 42, 364.
33. Richardson, K. A., Megens, H. J. J. J., Webb, J. D., and Van Sittert, N. J. (1996). Biological monitoring of butadiene exposure by measurement of haemoglobin adducts. Toxicology 113, 112-118.
34. Richardson, K. A., Peters, M. M. C. G., Megens, H. J. J. J., Van Elburg, P. A., Golding, B. T., Boogaard, P. J., Watson, W. P., and Van Sittert, N. J. (1998c). Identification of novel metabolites of butadiene monoepoxide in rats and mice. Chem. Res. Toxicol. 11, 1543-1555.
35. 14C-1,3-butadiene in rats and mice: Relevance to cancer susceptibility. Toxicol. Sci. 49, 186-201.
36. Sabourin, P. J., Burka, L. T., Bechtold, W. E., Dahl, A. R., Hoover, M. D., Chang, I-Y., and Henderson, R. F. (1992). Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetylcysteinyl)-butane, a novel metabolite of butadiene. Carcinogenesis 13, 1633-1638.
37. Segerbäck, D. (1990). Reaction products in hemoglobin and DNA after in vitro treatment with ethylene oxide and N-(2-hydroxyethyl)-N-nitrosurea. Carcinogenesis 11, 307-312.
38. Swenberg, J. A., Upton, P. B., Ranasinghe, A., Albertini, R., and Šrám, R. J. (1999). Hemoglobin adducts as biomarkers of butadiene exposure in workers from the Czech Republic. In Abstracts, Air Pollution: Understanding Air Toxics and Particles, p. 61. The Fifteenth Health Effects Institute Annual Conference, San Diego, CA.
39. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. C., Jr., and Henderson, R. F. (1995). Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 16, 1723-1731.
40. Törnqvist, M., Mowrer, J., Jensen, S., and Ehrenberg, L. (1986). Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal. Biochem. 154, 255-266.
41. Van Sittert, N. J., and Van Vliet, E. W. N. (1994). Monitoring occupational exposure to some industrial chemicals by determining hemoglobin adducts. Clin. Chem. 40, 1472-1475.